Atenolol 100mg tablets

Land: Verenigd Koninkrijk

Taal: Engels

Bron: MHRA (Medicines & Healthcare Products Regulatory Agency)

Werkstoffen:

Atenolol

Beschikbaar vanaf:

Mawdsley-Brooks & Company Ltd

ATC-code:

C07AB03

INN (Algemene Internationale Benaming):

Atenolol

Dosering:

100mg

farmaceutische vorm:

Oral tablet

Toedieningsweg:

Oral

klasse:

No Controlled Drug Status

Prescription-type:

Valid as a prescribable product

Product samenvatting:

BNF: 02040000

Bijsluiter

READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor
or pharmacist.
•
This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even
if their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1
What Atenolol is and what it is used for.
2
What you need to know before you take Atenolol.
3
How to take Atenolol.
4
Possible side effects.
5
How to store Atenolol.
6
Contents of the pack and other information.
WHAT ATENOLOL IS AND WHAT IT IS
USED FOR
1
Atenolol belongs to a group of medicines called
beta-blockers, which help your heart to beat more
slowly and with less force, reducing blood pressure.
Beta blockers also help blood vessels to open to
improve blood flow.
Atenolol is used to treat:
•
High blood pressure (hypertension)
•
Chest pain (angina pectoris)
•
Irregular heartbeat (cardiac dysrhythmias)
•
Protect the heart in the early treatment after a
heart attack
WHAT YOU NEED TO KNOW BEFORE
YOU TAKE ATENOLOL
2
DO NOT TAKE ATENOLOL IF:
•
YOU HAVE A HISTORY OF WHEEZING OR ASTHMA.
CONSULT YOUR DOCTOR OR PHARMACIST FIRST
•
You are allergic to Atenolol or any of the ingredients
of this medicine (listed in section 6)
•
You suffer from heart problems such as:
o Uncontrolled heart failure
o
2
nd
or 3
rd
degree heart block
o Weakened heart unable to pump blood around
the body (cardiogenic shock)
o A very slow heart rate (less than 45-50 beats per
minute) [bradycardia]
o Irregular heartbeat (sick sinus syndrome)
•
You have low blood pressure (hypotension)
•
You have very poor circulation
•
You have UNTREATED phaeochromocytoma
(tumour of the adrenal gland)
•
You suffer from an increased level of acid in the
blood (metabolic ac

Productkenmerken

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Atenolol 100mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Atenolol 100mg
For excipients, see 6.1.
3
PHARMACEUTICAL FORM
White, circular, biconvex, uncoated tablets with ‘FIL’ engraved
above the
score line, ‘100’ below the score line, on one side and plain on
the other side.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Atenolol 100mg tablets are indicated for the management of:
Hypertension
Angina pectoris
Cardiac arrhythmias
Acute myocardial infarction, as early intervention.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Adults:
_ _
_Hypertension: _
_ _
The majority of patients respond to a single oral dose of 100mg daily
though
some patients respond to 50mg, the effect being established fully
after one or
two weeks. A further reduction in blood pressure may be obtained by
combining atenolol tablets with other antihypertensive therapy such as
diuretics.
_Angina: _
The majority of patients respond to a single oral dose of 100mg daily
or to
50mg given twice daily. Increasing the dose above l00mg daily is
unlikely to
confer additional benefit.
_Cardiac arrhythmias. _
_ _
The initial dose for control of arrhythmias by intravenous application
of
atenolol is 2.5mg. This dose may be administered in intervals of 5
minutes
until the recommended effect is observed or until the maximum dose of
0.15mg per kg of body weight has been reached, respectively. When the
arrhythmia has been controlled with intravenous atenolol, the
recommended
oral maintenance dose of Atenolol tablets is a single daily dose of 50
- 100mg.
_ _
_Myocardial infarction: _
_ _
In those patients who are considered suitable for beta-blocker therapy
(presenting for treatment within 12 hours of the onset of chest pain),
appropriate intravenous beta-blocker therapy should be supplemented 15
minutes later by a single oral dose of 50mg atenolol
tablet providing intravenous therapy has been well tolerated. A
further oral
dose of
50mg Atenolol tablet should be given 12 hours late